| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.29 | 1e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.48 | 0.0003 |